ELIXIR Innovation and SME Forum: Turning big data into growth
Your organization wants to benefit from the big data revolution? You are looking to use Europe’s free bioinformatics resources in your company's R&D processes? You want to know about how your company can benefit from Swiss world-class bioinformatics for the life sciences?
Come to the ELIXIR Innovation and SME forum to learn how ELIXIR’s bioinformatics services and resources can help you. The forum will provide the opportunity to introduce you to some of the tools, data resources and services, allowing you to integrate these resources into your businesses planning.
Date: Tuesday 9. June at the [BC]2 conference
| 8:30-9:00 | Registration and welcome coffee | |
| 9:00-10:00 | Keynote lecture (room Montreal) | Christian von Mering University of Zurich & SIB Swiss Institute of Bioinformatics, Switzerland |
| 10:00-10:10 | Welcome and purpose of meeting (room Sydney) | Torsten Schwede Biozentrum University of Basel & SIB, [BC]2 Conference series chair |
| 10:10-10:30 | Introduction to ELIXIR | Andy Smith ELIXIR Hub |
| 10:30-11:00 | Presentation of SIB Swiss Institute of Bioinformatics | Ron Appel Executive Director SIB |
| 11:00-11:30 | Coffee Break | |
| 11:30-13:00 |
Session 1: SIB resources for industry |
|
| Lightning talks from SIB group leaders on their bioinformatics expertise serving the life science industry | ||
| Introduction |
Vanya Loroch |
|
|
Vital-IT and Swiss-Prot: from knowledge representation to big data analytics |
Ioannis Xenarios Group Leader SwissProt and Vital-IT |
|
|
nextProt: a new API and SPARQL-based search engine, their application to industry research needs |
Amos Bairoch Group Leader CALIPHO |
|
| Bgee database of gene expression | Marc Robinson Rechavi Group Leader Evolutionary Bioinformatics Group |
|
|
Clinical Bioinformatics: from sequences to therapies |
Niko Beerenwinkel Group Leader Computational Biology Group |
|
| Tools and resources to interpret disease-relevant genetic variation | Manolis Dermitzakis Group Leader Genomics of Complex Traits Group |
|
|
SWISS-MODEL – automated modelling of 3-dimensional protein structures and complexes |
Torsten Schwede Group Leader Computational Structural Biology |
|
|
Drug design, protein engineering and melanoma genomics |
Vincent Zoete Group Leader Molecular Modeling |
|
|
Bioinformatics Core Facility – BCF |
Frédéric Schütz Bioinformatics Core Facility |
|
| 13:00-14:00 | Lunch break | |
| 14:00-15:00 | Session 2: Genomic resources for industry | |
|
The European Genome Phenome Archive: a distributed resource for human research data |
Roderic Guigó Center for Genomic Regulations, Universitat Pompeu Fabra, Barcelona, Spain |
|
| IMGT®, the international ImMunoGeneTics information system® | Sofia Kossida University of Montpellier & IMGT, France |
|
| 15:00-16:00 | Session 3: Industry/academia collaboration | |
|
Structure-guided engineering of an enzyme for production of novel conjugate vaccines in bacteria. |
Michael Kowarik Head of Research, BSO, GlycoVaxyn AG |
|
| Genomics, transcriptomics and engineered CHO cell libraries driving Research Cell Bank generation of difficult-to-express proteins. | Igor Fisch President and CEO, Selexis |
|
| 16:00-16:30 | Break | |
| 16:30-17:30 | Session 4: The view from industry | |
| Data challenges and opportunities: an SME perspective | Jerome Wojcik Founder and CEO of Quartz Bio |
|
| The eTOX consortium: of the art of sharing the “unsharable” | François Pognan Executive Director - Biochemical & Translational Safety, Novartis Pharma |
|
| 17:30-18:00 | Summary and Conclusions | Vanya Loroch moderator |
| 18:00-20:00 | ELIXIR Networking Apero |